Related Experiment Video
Updated: Jul 9, 2026

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
Published on: May 1, 2020
[Rapamycin affects eIF- 4E expression in rat myocardial fibroblasts infected by Coxsackievirus B3]
Chun-Yuan Chen1, Yue-Nu Sun, Zuo-Cheng Yang
1Department of Pediatrics, Third Xiangya Hospital, Central South University, Changsha 410013, China. ccyzdh@126.com
Objective:
This study examined the effect of rapamycin, an inhibitor of mammalian target of rapamycin (mTOR), on eukaryotic initiation factor (eIF- 4E) expression in rat myocardial fibroblasts infected by Coxsackievirus B3 (CVB3) in order to identify the drug target for treatment of viral myocarditis.
Methods:
Primary cultured rat myocardial fibroblasts were treated with CVB3 with multiplicity of infection (MOI=0.5 PFU/cell). The experiment consisted of four groups in which the cultured rat fibroblasts cells were treated with CVB3, rapamycin (10 nM) and CVB3 + rapamycin or placebo (control). Experimental model of CVB3-infected myocardial fibroblasts was confirmed by detection of CVB3 mRNA expression with RT-PCR and observation of morphological changes of the infected cells with microscopy. eIF-4E expression was determined by both RT-PCR and Western Blot methods.
Results:
Morphological changes were found in the fibroblasts treated with MOI 0.5 PFU/cell of CVB3 by transmission electron microscope and the viral particles were found in the cytoplasm. CVB3 mRNA was expressed in CVB3-infected fibroblasts after 1, 2, and 3 days after infection and 2 days after passage. The gray scale values of the eIF- 4E /beta -actin in the control, the CVB3, the rapamycin and the CVB3+rapamycin groups were 0.73 +/- 0.07, 0.87 +/- 0.03, 0.32 +/- 0.03 and 0.56 +/- 0.04 respectively detected by RT-PCR, and were 0.79 +/- 0.09, 1.35 +/- 0.12, 0.55 +/- 0.04, and 0.62 +/- 0.07 respectively detected by Western blot. EIF- 4E expression in the CVB3 group was higher than that in the control group. Both the rapamycin and the CVB3+rapamycin groups had lower eIF- 4E expression than the control and the CVB3 groups.
Conclusions:
CVB3 can infect myocardial fibroblasts and up-regulate the eIF- 4E expression in rat myocardial fibroblasts. Rapamycin can inhibit eIF- 4E expression and may be a potential medicine for treatment of viral myocarditis. It was suspected that mTOR/eIF- 4E signal pathway in rat myocardial fibroblasts might play an important role in the pathogenesis of viral myocarditis.
Insights
Coxsackievirus B3 (CVB3) infection increases eukaryotic initiation factor 4E (eIF-4E) expression in heart cells. Rapamycin treatment inhibits eIF-4E, suggesting its potential for treating viral myocarditis.
Area of Science:
- Cardiovascular Research
- Virology
- Molecular Biology
Context:
- Viral myocarditis is a serious condition often caused by Coxsackievirus B3 (CVB3).
- Understanding the molecular mechanisms of CVB3 infection in heart cells is crucial for developing effective treatments.
- Eukaryotic initiation factor 4E (eIF-4E) plays a key role in protein synthesis and has been implicated in viral pathogenesis.
Purpose:
- To investigate the effect of rapamycin, an mTOR inhibitor, on eIF-4E expression in CVB3-infected rat myocardial fibroblasts.
- To determine if rapamycin could be a potential therapeutic agent for viral myocarditis.
Summary:
- CVB3 infection was confirmed in cultured rat myocardial fibroblasts through mRNA detection and morphological changes.
- CVB3 infection led to increased eIF-4E expression in myocardial fibroblasts.
- Rapamycin treatment, alone or in combination with CVB3, significantly reduced eIF-4E expression compared to controls.
Impact:
- This study identifies a potential drug target (mTOR/eIF-4E pathway) for managing viral myocarditis.
- Rapamycin demonstrates potential as a therapeutic agent for viral myocarditis by modulating eIF-4E levels.
- The findings contribute to understanding the pathogenesis of viral myocarditis at a molecular level.
More Related Videos
09:16Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
10:05Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5
Published on: November 13, 2015
Related Concept Videos
Myocarditis III: Medical Management
Cardiomyopathy IV: Restrictive Cardiomyopathy